Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
32
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Shafer Christina | Chief Commercial Officer | 19 | $0 | $47.7K | 2025-02-11 |
| Pfanstiel Steven | Chief Financial Officer | 20 | $0 | $62.8K | 2025-02-11 |
| Johnson Marvin | Director | 12 | $0 | $869 | 2025-02-11 |
| Hulihan Joseph | Chief Medical Officer | 24 | $0 | $61.2K | 2025-02-11 |
| Silverstein Christine Berni | Director | 11 | $0 | $0 | 2025-02-11 |
| Braunstein Scott | Executive Chairman | 32 | $131.5K | $193.0K | 2025-02-11 |
| Fischer Seth H. Z. | Director | 27 | $0 | $6.7K | 2025-02-11 |
| Ezickson Elan | Director | 20 | $0 | $5.8K | 2025-02-11 |
| MAYLEBEN TIMOTHY M | Director | 43 | $0 | $0 | 2025-02-11 |
| MANNING MARTHA E | VP, Gen. Counsel & Corp. Sec. | 23 | $0 | $43.0K | 2025-02-11 |
| Nochur Sara | Director | 9 | $0 | $0 | 2024-06-18 |
| Austin Charles | Director | 11 | $0 | $7.0K | 2024-06-18 |
| Noonberg Sarah B. | Director | 6 | $0 | $0 | 2024-06-18 |
| Arroyo Santiago | Director | 3 | $0 | $0 | 2022-02-04 |
| VITULLO NICOLE | Director, 10% Owner | 23 | $0 | $67.4K | 2022-02-04 |
| DOUGHERTY MICHAEL R | Director | 6 | $0 | $0 | 2022-02-04 |
| Smith Edward F | Former VP, CFO & Treasurer | 19 | $0 | $876.4K | 2021-03-09 |
| Carrazana Enrique J. | Director | 13 | $0 | $0 | 2021-01-15 |
| Lorianne Masuoka K. | Chief Medical Officer | 3 | $0 | $0 | 2019-08-21 |
| Cashman Christopher Michael | President and CEO | 22 | $20.0K | $85.6K | 2019-03-18 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 5 | $0 | $10.03M | 2017-12-19 |
| Shepard Jay | Director | 6 | $0 | $0 | 2017-01-17 |
| Sofinnova Management VI, L.L.C. | 10% Owner | 27 | $6.01M | $1.04M | 2016-10-20 |
| Canaan Partners VII LLC | Director, 10% Owner | 11 | $5.00M | $442.1K | 2016-08-08 |
| Patroneva Albena | Chief Medical Officer | 4 | $0 | $0 | 2016-08-03 |
| Mehra Anand | Director, 10% Owner | 4 | $0 | $0 | 2016-08-03 |
| Canaan VII LP | Director, 10% Owner | 6 | $0 | $593.5K | 2016-07-29 |
| Bloch Stephen M | Director | 20 | $5.00M | $0 | 2015-09-28 |
| Farfel Gail M | Chief Clinical Dev & Reg Offic | 4 | $0 | $284.4K | 2015-04-21 |
| Gopka Anton | Director | 1 | $0 | $0 | 2014-09-30 |
| Domain Partners VI, L.P. | 10% Owner | 5 | $3.36M | $0 | 2014-08-05 |
| BLAIR JAMES C | 10% Owner | 4 | $0 | $0 | 2014-08-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Silverstein Christine Berni | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 20,900 | — | $0 | 0 | SEC↗ |
| Silverstein Christine Berni | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 10,450 | — | $0 | 0 | SEC↗ |
| Silverstein Christine Berni | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 32,400 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 360,000 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 335,650 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 167,825 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 7,500 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 15,917 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 200,000 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 450,000 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 290,000 | — | $0 | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 193,050 | — | $0 | 0 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 49,125 | — | $0 | 0 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 128,000 | — | $0 | 0 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 15,000 | — | $0 | 0 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,900 | — | $0 | 0 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 98,250 | — | $0 | 0 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 78,188 | — | $0 | 0 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,300 | — | $0 | 0 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 114,600 | — | $0 | 0 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 126,585 | — | $0 | 0 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 74,475 | — | $0 | 0 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | D To issuer deriv | 2025-02-11 | 2025-02-11 | 220,000 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 10,450 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 20,900 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,200 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 12,375 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,500 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 25,000 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 8,750 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 8,750 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 2,625 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 1,575 | — | $0 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 1,925 | — | $0 | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,900 | — | $0 | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer deriv | 2025-02-11 | 2025-02-11 | 74,468 | — | $0 | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer deriv | 2025-02-11 | 2025-02-11 | 98,250 | — | $0 | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer deriv | 2025-02-11 | 2025-02-11 | 75,000 | — | $0 | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer deriv | 2025-02-11 | 2025-02-11 | 49,125 | — | $0 | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,500 | — | $0 | 0 | SEC↗ |
| Johnson Marvin | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 20,900 | — | $0 | 0 | SEC↗ |
| Johnson Marvin | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 10,450 | — | $0 | 0 | SEC↗ |
| Johnson Marvin | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 32,400 | — | $0 | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 115,000 | — | $0 | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 77,175 | — | $0 | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 115,418 | — | $0 | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 98,250 | — | $0 | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 49,125 | — | $0 | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 101,250 | — | $0 | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-11 | 2025-02-11 | 100,000 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 12,375 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,200 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 20,900 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 10,450 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 3,850 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 2,625 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 8,750 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 8,750 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 25,000 | — | $0 | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,500 | — | $0 | 0 | SEC↗ |
| Ezickson Elan | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,500 | — | $0 | 0 | SEC↗ |
| Ezickson Elan | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 25,000 | — | $0 | 0 | SEC↗ |
| Ezickson Elan | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 12,375 | — | $0 | 0 | SEC↗ |
| Ezickson Elan | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,200 | — | $0 | 0 | SEC↗ |
| Ezickson Elan | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 10,450 | — | $0 | 0 | SEC↗ |
| Ezickson Elan | Director | D To issuer deriv | 2025-02-11 | 2025-02-11 | 20,900 | — | $0 | 0 | SEC↗ |
| Silverstein Christine Berni | Director | D To issuer | 2025-02-11 | 2025-02-11 | 4,702 | $0.55 | $2.6K | 0 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer | 2025-02-11 | 2025-02-11 | 179,536 | $0.55 | $98.7K | 0 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer | 2025-02-11 | 2025-02-11 | 48,628 | $0.55 | $26.7K | 0 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | D To issuer | 2025-02-11 | 2025-02-11 | 62,470 | $0.55 | $34.4K | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer | 2025-02-11 | 2025-02-11 | 2,300 | $0.55 | $1.3K | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer | 2025-02-11 | 2025-02-11 | 48,077 | $0.55 | $26.4K | 0 | SEC↗ |
| Johnson Marvin | Director | D To issuer | 2025-02-11 | 2025-02-11 | 7,101 | $0.55 | $3.9K | 0 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer | 2025-02-11 | 2025-02-11 | 55,570 | $0.55 | $30.6K | 0 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer | 2025-02-11 | 2025-02-11 | 2,300 | $0.55 | $1.3K | 0 | SEC↗ |
| Ezickson Elan | Director | D To issuer | 2025-02-11 | 2025-02-11 | 2,300 | $0.55 | $1.3K | 0 | SEC↗ |
| Silverstein Christine Berni | Director | D To issuer | 2025-02-07 | 2025-02-11 | 9,398 | $0.55 | $5.2K | 4,702 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | D To issuer | 2025-02-07 | 2025-02-11 | 125,064 | $0.55 | $68.8K | 179,536 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | D To issuer | 2025-02-07 | 2025-02-11 | 18,778 | $0.55 | $10.3K | 48,628 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | D To issuer | 2025-02-07 | 2025-02-11 | 17,303 | $0.55 | $9.5K | 62,470 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer | 2025-02-07 | 2025-02-11 | 1,660 | $0.55 | $913 | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer | 2025-02-07 | 2025-02-11 | 10,637 | $0.55 | $5.9K | 0 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer | 2025-02-07 | 2025-02-11 | 4,600 | $0.55 | $2.5K | 2,300 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | D To issuer | 2025-02-07 | 2025-02-11 | 1,660 | $0.55 | $913 | 0 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | D To issuer | 2025-02-07 | 2025-02-11 | 12,186 | $0.55 | $6.7K | 48,077 | SEC↗ |
| Johnson Marvin | Director | D To issuer | 2025-02-07 | 2025-02-11 | 5,389 | $0.55 | $3.0K | 7,101 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | D To issuer | 2025-02-07 | 2025-02-11 | 17,155 | $0.55 | $9.4K | 55,570 | SEC↗ |
| Fischer Seth H. Z. | Director | D To issuer | 2025-02-07 | 2025-02-11 | 12,707 | $0.55 | $7.0K | 2,300 | SEC↗ |
| Ezickson Elan | Director | D To issuer | 2025-02-07 | 2025-02-11 | 8,600 | $0.55 | $4.7K | 2,300 | SEC↗ |
| Johnson Marvin | Director | S Sale | 2025-01-21 | 2025-01-23 | 1,610 | $0.54 | $869 | 12,490 | SEC↗ |
| Ezickson Elan | Director | S Sale | 2025-01-21 | 2025-01-23 | 1,600 | $0.54 | $864 | 10,900 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | G Gift | 2024-10-10 | 2024-10-15 | 4,980 | — | $0 | 13,957 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | G Gift | 2024-10-10 | 2024-10-15 | 1,660 | — | $0 | 10,637 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | G Gift | 2024-10-10 | 2024-10-15 | 1,660 | — | $0 | 12,297 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | P Buy | 2024-08-14 | 2025-02-11 | 5,933 | $1.10 | $6.5K | 304,600 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | S Sale | 2024-08-05 | 2024-08-07 | 12,145 | $1.13 | $13.7K | 298,667 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | S Sale | 2024-08-05 | 2024-08-07 | 4,828 | $1.13 | $5.5K | 72,725 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | S Sale | 2024-08-05 | 2024-08-07 | 3,621 | $1.13 | $4.1K | 60,263 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | S Sale | 2024-08-05 | 2024-08-07 | 4,657 | $1.13 | $5.3K | 79,773 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | S Sale | 2024-08-05 | 2024-08-07 | 3,820 | $1.14 | $4.4K | 67,406 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | A Award deriv | 2024-06-18 | 2024-06-20 | 167,825 | — | $0 | 167,825 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | A Award deriv | 2024-06-18 | 2024-06-20 | 57,300 | — | $0 | 57,300 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | A Award deriv | 2024-06-18 | 2024-06-20 | 49,125 | — | $0 | 49,125 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | A Award deriv | 2024-06-18 | 2024-06-20 | 49,125 | — | $0 | 49,125 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | A Award deriv | 2024-06-18 | 2024-06-20 | 49,125 | — | $0 | 49,125 | SEC↗ |
| Austin Charles | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Ezickson Elan | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Johnson Marvin | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Silverstein Christine Berni | Director | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | A Award | 2024-06-18 | 2024-06-20 | 37,300 | — | $0 | 310,812 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | A Award | 2024-06-18 | 2024-06-20 | 12,733 | — | $0 | 84,430 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | A Award | 2024-06-18 | 2024-06-20 | 10,918 | — | $0 | 77,553 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | A Award | 2024-06-18 | 2024-06-20 | 10,918 | — | $0 | 63,884 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | A Award | 2024-06-18 | 2024-06-20 | 10,918 | — | $0 | 71,226 | SEC↗ |
| Austin Charles | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 12,177 | SEC↗ |
| Ezickson Elan | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 12,500 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 12,926 | SEC↗ |
| Johnson Marvin | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 14,100 | SEC↗ |
| Nochur Sara | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 13,250 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 24,375 | SEC↗ |
| Noonberg Sarah B. | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 14,100 | SEC↗ |
| Silverstein Christine Berni | Director | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 14,100 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | M Exercise deriv | 2024-03-27 | 2024-03-27 | 50,000 | — | $0 | 200,000 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | M Exercise | 2024-03-27 | 2024-03-27 | 50,000 | $4.28 | $214.0K | 273,512 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | S Sale | 2024-02-20 | 2024-02-22 | 1,894 | $9.57 | $18.1K | 52,966 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | S Sale | 2024-02-20 | 2024-02-22 | 2,153 | $9.56 | $20.6K | 60,308 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | S Sale | 2024-02-16 | 2024-02-21 | 11,850 | $9.94 | $117.8K | 223,512 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | S Sale | 2024-02-16 | 2024-02-21 | 3,092 | $9.97 | $30.8K | 71,697 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | S Sale | 2024-02-16 | 2024-02-21 | 2,814 | $9.98 | $28.1K | 66,635 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | A Award deriv | 2024-01-18 | 2024-01-19 | 335,650 | — | $0 | 335,650 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | A Award deriv | 2024-01-18 | 2024-01-19 | 114,600 | — | $0 | 114,600 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | A Award deriv | 2024-01-18 | 2024-01-19 | 98,250 | — | $0 | 98,250 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | A Award deriv | 2024-01-18 | 2024-01-19 | 98,250 | — | $0 | 98,250 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | A Award deriv | 2024-01-18 | 2024-01-19 | 98,250 | — | $0 | 98,250 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Austin Charles | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Ezickson Elan | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Silverstein Christine Berni | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Johnson Marvin | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | A Award | 2024-01-18 | 2024-01-19 | 74,600 | — | $0 | 235,362 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | A Award | 2024-01-18 | 2024-01-19 | 25,465 | — | $0 | 74,789 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | A Award | 2024-01-18 | 2024-01-19 | 21,835 | — | $0 | 69,449 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | A Award | 2024-01-18 | 2024-01-19 | 21,835 | — | $0 | 54,860 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | A Award | 2024-01-18 | 2024-01-19 | 21,835 | — | $0 | 62,461 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 22,075 | SEC↗ |
| Austin Charles | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 9,877 | SEC↗ |
| Nochur Sara | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 10,950 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 10,626 | SEC↗ |
| Ezickson Elan | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 10,200 | SEC↗ |
| Silverstein Christine Berni | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 11,800 | SEC↗ |
| Johnson Marvin | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 11,800 | SEC↗ |
| Noonberg Sarah B. | Director | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 11,800 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | S Sale | 2023-08-08 | 2023-08-08 | 13 | $8.93 | $116 | 47,614 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | S Sale | 2023-08-08 | 2023-08-08 | 11 | $8.93 | $98 | 33,025 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | S Sale | 2023-08-08 | 2023-08-08 | 14 | $8.93 | $125 | 49,324 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | S Sale | 2023-08-08 | 2023-08-08 | 30 | $8.94 | $268 | 160,762 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | S Sale | 2023-08-08 | 2023-08-08 | 11 | $8.93 | $98 | 40,626 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | S Sale | 2023-08-07 | 2023-08-08 | 2,889 | $9.55 | $27.6K | 47,627 | SEC↗ |
| MANNING MARTHA E | SVP, GEN. COUNSEL & CORP. SE | S Sale | 2023-08-07 | 2023-08-08 | 2,169 | $9.54 | $20.7K | 33,036 | SEC↗ |
| Pfanstiel Steven | CFO AND COO | S Sale | 2023-08-07 | 2023-08-08 | 2,790 | $9.54 | $26.6K | 49,338 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | S Sale | 2023-08-07 | 2023-08-08 | 6,413 | $9.55 | $61.2K | 160,792 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | S Sale | 2023-08-07 | 2023-08-08 | 2,385 | $9.52 | $22.7K | 40,637 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2023-05-16 | 2023-05-17 | 32,400 | — | $0 | 32,400 | SEC↗ |
| Noonberg Sarah B. | Director | A Award | 2023-05-16 | 2023-05-17 | 7,200 | — | $0 | 7,200 | SEC↗ |
| Johnson Marvin | Director | A Award deriv | 2023-04-17 | 2023-04-19 | 32,400 | — | $0 | 32,400 | SEC↗ |
| Johnson Marvin | Director | A Award | 2023-04-17 | 2023-04-19 | 7,200 | — | $0 | 7,200 | SEC↗ |
| Austin Charles | Director | S Sale | 2023-02-06 | 2023-02-08 | 1,073 | $6.49 | $7.0K | 5,277 | SEC↗ |
| Ezickson Elan | Director | S Sale | 2023-02-06 | 2023-02-08 | 750 | $6.56 | $4.9K | 5,600 | SEC↗ |
| Fischer Seth H. Z. | Director | S Sale | 2023-02-06 | 2023-02-08 | 1,018 | $6.54 | $6.7K | 6,026 | SEC↗ |
| Silverstein Christine Berni | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 32,400 | — | $0 | 32,400 | SEC↗ |
| Austin Charles | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 16,200 | — | $0 | 16,200 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 16,200 | — | $0 | 16,200 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 16,200 | — | $0 | 16,200 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 16,200 | — | $0 | 16,200 | SEC↗ |
| Ezickson Elan | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 16,200 | — | $0 | 16,200 | SEC↗ |
| MANNING MARTHA E | VP, GEN. COUNSEL & CORP. SEC | A Award deriv | 2023-01-26 | 2023-01-30 | 74,468 | — | $0 | 74,468 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | A Award deriv | 2023-01-26 | 2023-01-30 | 78,188 | — | $0 | 78,188 | SEC↗ |
| Pfanstiel Steven | CHIEF FINANCIAL OFFICER | A Award deriv | 2023-01-26 | 2023-01-30 | 126,585 | — | $0 | 126,585 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | A Award deriv | 2023-01-26 | 2023-01-30 | 115,418 | — | $0 | 115,418 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | A Award deriv | 2023-01-26 | 2023-01-30 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Silverstein Christine Berni | Director | A Award | 2023-01-26 | 2023-01-30 | 7,200 | — | $0 | 7,200 | SEC↗ |
| Austin Charles | Director | A Award | 2023-01-26 | 2023-01-30 | 3,600 | — | $0 | 6,350 | SEC↗ |
| Nochur Sara | Director | A Award | 2023-01-26 | 2023-01-30 | 3,600 | — | $0 | 6,350 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award | 2023-01-26 | 2023-01-30 | 3,600 | — | $0 | 17,475 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award | 2023-01-26 | 2023-01-30 | 3,600 | — | $0 | 7,044 | SEC↗ |
| Ezickson Elan | Director | A Award | 2023-01-26 | 2023-01-30 | 3,600 | — | $0 | 6,350 | SEC↗ |
| MANNING MARTHA E | VP, GEN. COUNSEL & CORP. SEC | A Award | 2023-01-26 | 2023-01-30 | 16,548 | — | $0 | 35,205 | SEC↗ |
| Shafer Christina | CHIEF COMMERCIAL OFFICER | A Award | 2023-01-26 | 2023-01-30 | 17,375 | — | $0 | 43,022 | SEC↗ |
| Pfanstiel Steven | CHIEF FINANCIAL OFFICER | A Award | 2023-01-26 | 2023-01-30 | 28,130 | — | $0 | 52,128 | SEC↗ |
| Hulihan Joseph | CHIEF MEDICAL OFFICER | A Award | 2023-01-26 | 2023-01-30 | 25,648 | — | $0 | 50,516 | SEC↗ |
| Braunstein Scott | CHAIRMAN AND CEO | A Award | 2023-01-26 | 2023-01-30 | 80,000 | — | $0 | 167,205 | SEC↗ |
| Shafer Christina | Chief Commercial Officer | F Tax w/h | 2022-11-09 | 2022-11-14 | 1,505 | $4.70 | $7.1K | 25,647 | SEC↗ |
| Braunstein Scott | Chairman and CEO | A Award | 2022-05-24 | 2022-05-26 | 19,305 | — | $0 | 87,205 | SEC↗ |
| Hulihan Joseph | Chief Medical Officer | A Award | 2022-05-24 | 2022-05-26 | 7,718 | — | $0 | 24,868 | SEC↗ |
| MANNING MARTHA E | VP Gen Counsel and Corp Sec. | A Award | 2022-05-24 | 2022-05-26 | 5,790 | — | $0 | 18,657 | SEC↗ |
| Arroyo Santiago | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Austin Charles | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Braunstein Scott | Chief Executive Officer | A Award deriv | 2022-02-04 | 2022-02-07 | 193,050 | — | $0 | 193,050 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Ezickson Elan | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Hulihan Joseph | Chief Medical Officer | A Award deriv | 2022-02-04 | 2022-02-07 | 77,175 | — | $0 | 77,175 | SEC↗ |
| MANNING MARTHA E | VP Gen Counsel and Corp Sec. | A Award deriv | 2022-02-04 | 2022-02-07 | 57,900 | — | $0 | 57,900 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Pfanstiel Steven | Chief Financial Officer | A Award deriv | 2022-02-04 | 2022-02-07 | 74,475 | — | $0 | 74,475 | SEC↗ |
| VITULLO NICOLE | Director | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| Arroyo Santiago | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Austin Charles | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Braunstein Scott | Chief Executive Officer | A Award | 2022-02-04 | 2022-02-07 | 42,900 | — | $0 | 67,900 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 3,312 | SEC↗ |
| Ezickson Elan | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 3,444 | SEC↗ |
| Hulihan Joseph | Chief Medical Officer | A Award | 2022-02-04 | 2022-02-07 | 17,150 | — | $0 | 17,150 | SEC↗ |
| MANNING MARTHA E | VP Gen Counsel and Corp Sec. | A Award | 2022-02-04 | 2022-02-07 | 12,867 | — | $0 | 12,867 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 13,875 | SEC↗ |
| Nochur Sara | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Pfanstiel Steven | Chief Financial Officer | A Award | 2022-02-04 | 2022-02-07 | 16,550 | — | $0 | 16,550 | SEC↗ |
| VITULLO NICOLE | Director | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 6,442 | SEC↗ |
| Arroyo Santiago | Director | A Award deriv | 2021-07-01 | 2021-07-02 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Pfanstiel Steven | CFO | A Award deriv | 2021-04-12 | 2021-04-13 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2021-03-22 | 2021-03-24 | 33,000 | — | $0 | 33,000 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2021-03-16 | 2021-03-16 | 6,192 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2021-03-16 | 2021-03-16 | 11,612 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2021-03-16 | 2021-03-16 | 2,717 | — | $0 | 3,692 | SEC↗ |
| VITULLO NICOLE | Director | S Sale | 2021-03-15 | 2021-03-16 | 4,250 | $15.87 | $67.4K | 0 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2021-03-12 | 2021-03-16 | 6,192 | — | $0 | 6,192 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2021-03-12 | 2021-03-16 | 619,221 | — | $0 | 0 | SEC↗ |
| Smith Edward F | Former VP, CFO & Treasurer | M Exercise deriv | 2021-03-09 | 2021-03-11 | 35,927 | — | $0 | 0 | SEC↗ |
| Smith Edward F | Former VP, CFO & Treasurer | S Sale | 2021-03-09 | 2021-03-11 | 40,356 | $17.80 | $718.3K | 13,288 | SEC↗ |
| Smith Edward F | Former VP, CFO & Treasurer | M Exercise | 2021-03-09 | 2021-03-11 | 35,927 | $4.16 | $149.5K | 53,644 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2021-01-15 | 2021-01-19 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MANNING MARTHA E | VP Gen Counsel and Corp Sec. | A Award deriv | 2021-01-15 | 2021-01-19 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Hulihan Joseph | Chief Medical Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2021-01-15 | 2021-01-19 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Ezickson Elan | Director | A Award deriv | 2021-01-15 | 2021-01-19 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Austin Charles | Director | A Award deriv | 2021-01-15 | 2021-01-19 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Braunstein Scott | Chief Executive Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 290,000 | — | $0 | 290,000 | SEC↗ |
| Carrazana Enrique J. | Director | A Award deriv | 2021-01-15 | 2021-01-19 | 16,500 | — | $0 | 16,500 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2021-01-15 | 2021-01-19 | 16,500 | — | $0 | 16,500 | SEC↗ |
| VITULLO NICOLE | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Austin Charles | Director | A Award deriv | 2020-07-29 | 2020-08-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MANNING MARTHA E | VP, Gen. Counsel & Corp. Sec | A Award deriv | 2020-06-15 | 2020-06-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Smith Edward F | CFO | S Sale | 2020-01-30 | 2020-02-03 | 2,380 | $2.05 | $4.9K | 17,717 | SEC↗ |
| VITULLO NICOLE | Director | A Award deriv | 2020-01-08 | 2020-11-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VITULLO NICOLE | Director | A Award deriv | 2020-01-08 | 2020-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hulihan Joseph | Chief Medical Officer | A Award deriv | 2020-01-08 | 2020-01-10 | 405,000 | — | $0 | 405,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2020-01-08 | 2020-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Carrazana Enrique J. | Director | A Award deriv | 2020-01-08 | 2020-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2020-01-08 | 2020-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2020-01-08 | 2020-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Smith Edward F | CFO | A Award deriv | 2020-01-08 | 2020-01-10 | 765,000 | — | $0 | 765,000 | SEC↗ |
| Braunstein Scott | Chief Executive Officer | A Award deriv | 2020-01-08 | 2020-01-10 | 1,800,000 | — | $0 | 1,800,000 | SEC↗ |
| Braunstein Scott | Chief Executive Officer | P Buy | 2019-12-13 | 2019-12-13 | 100,000 | $1.25 | $125.0K | 100,000 | SEC↗ |
| Ezickson Elan | Director | A Award deriv | 2019-12-11 | 2019-12-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Smith Edward F | CFO | A Award deriv | 2019-08-21 | 2019-08-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Lorianne Masuoka K. | Chief Medical Officer | A Award deriv | 2019-08-21 | 2019-08-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Braunstein Scott | Executive Chairman | A Award deriv | 2019-08-06 | 2019-08-08 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Smith Edward F | CFO | S Sale | 2019-05-16 | 2019-05-20 | 24,211 | $5.03 | $121.8K | 20,097 | SEC↗ |
| Cashman Christopher Michael | CEO | M Exercise deriv | 2019-03-18 | 2019-03-20 | 31,662 | — | $0 | 0 | SEC↗ |
| Cashman Christopher Michael | CEO | M Exercise | 2019-03-18 | 2019-03-20 | 31,662 | $1.04 | $32.9K | 271,423 | SEC↗ |
| VITULLO NICOLE | Director | A Award deriv | 2019-02-26 | 2019-02-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Carrazana Enrique J. | Director | A Award deriv | 2019-02-26 | 2019-02-28 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Braunstein Scott | Executive Chairman | A Award deriv | 2019-02-26 | 2019-02-28 | 240,000 | — | $0 | 240,000 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2019-02-26 | 2019-02-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2019-02-26 | 2019-02-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2019-02-26 | 2019-02-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Lorianne Masuoka K. | Chief Medical Officer | A Award deriv | 2019-02-26 | 2019-02-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Smith Edward F | CFO | A Award deriv | 2019-02-26 | 2019-02-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Smith Edward F | CFO | S Sale | 2019-01-29 | 2019-01-30 | 2,492 | $3.06 | $7.6K | 44,308 | SEC↗ |
| Cashman Christopher Michael | CEO | S Sale | 2019-01-28 | 2019-01-30 | 8,142 | $3.13 | $25.5K | 239,761 | SEC↗ |
| Smith Edward F | CFO | S Sale | 2018-01-29 | 2018-01-29 | 3,000 | $7.91 | $23.7K | 49,800 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2018-01-22 | 2018-01-24 | 2,250 | — | $0 | 46,450 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2018-01-22 | 2018-01-24 | 2,250 | — | $0 | 3,900 | SEC↗ |
| Cashman Christopher Michael | CEO | S Sale | 2018-01-18 | 2018-01-22 | 9,566 | $6.28 | $60.1K | 247,903 | SEC↗ |
| Bain Capital Life Sciences Inv | 10% Owner | S Sale | 2017-12-19 | 2017-12-19 | 94,771 | $7.62 | $722.2K | 4,032,682 | SEC↗ |
| Bain Capital Life Sciences Inv | 10% Owner | S Sale | 2017-12-19 | 2017-12-19 | 55,229 | $7.11 | $392.7K | 3,977,453 | SEC↗ |
| Bain Capital Life Sciences Inv | 10% Owner | S Sale | 2017-12-18 | 2017-12-19 | 300,000 | $7.50 | $2.25M | 4,127,453 | SEC↗ |
| Bain Capital Life Sciences Inv | 10% Owner | S Sale | 2017-12-15 | 2017-12-19 | 102,882 | $8.64 | $888.9K | 4,427,453 | SEC↗ |
| Bain Capital Life Sciences Inv | 10% Owner | S Sale | 2017-12-15 | 2017-12-19 | 719,665 | $8.02 | $5.77M | 4,530,335 | SEC↗ |
| Smith Edward F | CFO | A Award deriv | 2017-12-06 | 2017-12-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Carrazana Enrique J. | Director | A Award deriv | 2017-12-06 | 2017-12-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Cashman Christopher Michael | CEO | A Award deriv | 2017-12-06 | 2017-12-08 | 500,000 | — | $0 | 500,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2017-12-06 | 2017-12-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Fischer Seth H. Z. | Director | A Award deriv | 2017-12-06 | 2017-12-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Lorianne Masuoka K. | Chief Medical Officer | A Award deriv | 2017-12-06 | 2017-12-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MAYLEBEN TIMOTHY M | Director | A Award deriv | 2017-12-06 | 2017-12-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VITULLO NICOLE | Director | A Award deriv | 2017-12-06 | 2017-12-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2017-09-11 | 2017-09-11 | 1,650 | — | $0 | 6,150 | SEC↗ |
| VITULLO NICOLE | Director | J Other | 2017-09-11 | 2017-09-11 | 1,650 | — | $0 | 44,200 | SEC↗ |
| Cashman Christopher Michael | CEO | A Award | 2017-01-17 | 2018-01-22 | 60,600 | — | $0 | 257,469 | SEC↗ |
| Smith Edward F | CFO | A Award | 2017-01-17 | 2018-01-29 | 25,200 | — | $0 | 52,800 | SEC↗ |
| Carrazana Enrique J. | Director | A Award | 2017-01-17 | 2018-01-29 | 28,500 | — | $0 | 31,800 | SEC↗ |